(Q46334574)

21 December 2017

title

Comparison of loracarbef (LY163892) versus amoxicillin in the treatment of bronchopneumonia and lobar pneumonia (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1463527

29 September 2022

0 references

1 reference

O. Müller

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1463527

29 September 2022

K. Wettich

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1463527

29 September 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1463527

29 September 2022

publication date

1 May 1992

1 reference

21 December 2017

published in

Infection

1 reference

21 December 2017

volume

20

1 reference

21 December 2017

issue

3

1 reference

21 December 2017

page(s)

176-182

1 reference

21 December 2017

Long-Term Epidemiology of Infections with Mycoplasma pneumoniae

cites work

1 reference

https://api.crossref.org/works/10.1007%2FBF01704619

Severe Community-acquired Pneumonia: Epidemiology and Prognostic Factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01704619

Antimicrobial resistance among respiratory isolates of Haemophilus influenzae, Moraxella catarrhalis, and Streptococcus pneumoniae in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01704619

In vitro activities of LY163892, cefaclor, and cefuroxime

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01704619

Comparative in vitro activities of several new fluoroquinolones and beta-lactam antimicrobial agents against community isolates of Streptococcus pneumoniae

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01704619

In vitro susceptibilities of common pediatric pathogens to LY163892.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01704619

Community-Acquired Bacterial Pneumonia in the Elderly

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01704619

Influence of storage and susceptibility test conditions on stability and activity of LY163892 and four other cephalosporins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01704619

In vitro activity of LY163892 against pathogens isolated from pediatric patients.

21 January 2018

1 reference

12 December 2020

In vitro and in vivo antibacterial activity of KT3777, a new orally active carbacephem.

1 reference

12 December 2020

Comparative reactivity of 1-carba-1-dethiacephalosporins with cephalosporins

1 reference

12 December 2020

Mixed Streptococcus pneumoniae and gram-negative bacillary pneumonia in the elderly

1 reference

12 December 2020

C(3)-cyclopropyl cephems and carbacephems

1 reference

12 December 2020

Community-acquired pneumonia in adults in British hospitals in 1982-1983: a survey of aetiology, mortality, prognostic factors and outcome. The British Thoracic Society and the Public Health Laboratory Service

1 reference

12 December 2020

Etiology of community-acquired pneumonia

1 reference

12 December 2020

Prognosis in community-acquired pneumonia requiring treatment in hospital. Importance of predisposing and complicating factors, and of diagnostic procedures

1 reference

12 December 2020

Beta-lactamase hydrolysis and inhibition studies of the new 1-carbacephem LY163892.

1 reference

12 December 2020

Aetiology, outcome and prognostic factors in community-acquired pneumonia requiring hospitalization

1 reference

12 December 2020

Antimicrobial activity of LY163892, an orally administered 1-carbacephem

1 reference

12 December 2020

Incidence, etiology, and outcome of nosocomial pneumonia in mechanically ventilated patients

1 reference

12 December 2020

In vitro activity and beta-lactamase stability of LY163892.

1 reference

12 December 2020

In-vitro activity and beta-lactamase stability of LY163892.

1 reference

12 December 2020

In-vitro activity of cefprozil (BMY 28100) and loracarbef (LY 163892) against pathogens obtained from middle ear fluid

1 reference

12 December 2020

Effect of tobacco and nicotine on growth of Haemophilus influenzae in vitro

1 reference

12 December 2020

Comparative in-vitro activity of a new oral carbacephem, LY163892.

1 reference

12 December 2020

Therapeutics of community-acquired pneumonias

1 reference

12 December 2020

The effect of prescribed daily dose frequency on patient medication compliance

1 reference

12 December 2020

3-Sulfonyl-1-carba-1-dethiacephems

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF01704619

1 reference

21 December 2017

1 reference

21 December 2017